스포츠 의학용 혈액 기반 바이오마커 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 유형별, 지역별, 경쟁별(2020-2030년)

Global Blood-based Biomarker For Sports Medicine Market was valued at USD 758.45 Million in 2024 and is expected to reach USD 1057.72 Million by 2030 with a CAGR of 5.66% during the forecast period. The global blood-based biomarker market for sports medicine is experiencing rapid growth as advancements in medical diagnostics drive the demand for personalized and precise athlete care. Blood-based biomarkers have gained traction in the field of sports medicine due to their ability to provide real-time insights into an athlete's physiological status, injury risks, and recovery progress. These biomarkers, which include proteins, metabolites, and genetic markers, offer a non-invasive and objective means of monitoring various aspects of athletic performance and health. One of the primary drivers of market growth is the increasing incidence of sports-related injuries. As professional and amateur athletes strive for peak performance, injuries such as muscle strains, ligament tears, and concussions have become common. Blood-based biomarkers enable early detection of tissue damage, inflammation, and stress-related conditions, allowing for timely interventions that can enhance recovery and prevent further complications. Additionally, the growing emphasis on personalized sports medicine has fueled the adoption of these biomarkers, as they enable tailored training and rehabilitation plans based on an individual's unique physiological responses.

Advancements in biotechnology and biomarker discovery have also propelled the market forward. Continuous research into novel biomarkers has expanded the range of measurable parameters, from muscle damage indicators like creatine kinase (CK) and lactate dehydrogenase (LDH) to markers of oxidative stress and inflammation, such as C-reactive protein (CRP) and interleukins. These innovations are not only improving diagnostic accuracy but also facilitating real-time monitoring through wearable and point-of-care testing devices, further driving market demand.

Key Market Drivers

Rising Sports Injuries and Need for Early Detection

The increasing incidence of sports injuries across all levels of athletic participation is a major driver for the global blood-based biomarker for the sports medicine market. Athletes, both professional and amateur, are experiencing rising cases of muscle tears, ligament injuries, concussions, and stress fractures due to the growing intensity and competitiveness in sports. Traditional diagnostic methods, such as imaging techniques and physical assessments, often fail to detect early signs of damage, leading to delayed treatment and prolonged recovery periods. This has fueled the demand for blood-based biomarkers, which offer a minimally invasive and highly accurate means of detecting physiological and biochemical changes associated with sports-related injuries. According to the National Safety Council, in 2023, approximately 3.7 million individuals received emergency medical treatment for injuries related to sports and recreational equipment. The activities most commonly linked to these injuries include exercise, cycling, and basketball. One of the key advantages of blood-based biomarkers in sports medicine is their ability to provide early detection of injuries such as concussions and muscle damage. Biomarkers such as creatine kinase (CK), myoglobin, and C-reactive protein (CRP) can indicate muscle stress, inflammation, and tissue breakdown, allowing medical professionals to intervene before severe damage occurs. In addition, neuro biomarkers like S100 calcium-binding protein B (S100B) and tau protein are gaining attention for their role in detecting mild traumatic brain injuries (TBIs) in athletes, particularly in contact sports such as football, boxing, and rugby. The ability of these biomarkers to detect even subtle injuries has increased their adoption in sports medicine, as they facilitate personalized treatment plans and prevent long-term complications.

Key Market Trends

Technological Advancements

The blood-based biomarker for sports medicine market is witnessing significant growth, driven primarily by advancements in technology. These innovations are reshaping how biomarkers are detected, analyzed, and utilized in sports medicine to enhance athlete performance, injury prevention, and recovery monitoring. With the integration of cutting-edge diagnostic tools, artificial intelligence (AI), and wearable biosensors, the landscape of sports medicine is undergoing a transformation, making blood-based biomarkers more efficient and accessible. One of the major breakthroughs in this field is the development of high-sensitivity detection techniques, such as next-generation sequencing (NGS), mass spectrometry, and microfluidic platforms. These technologies have enhanced the precision of biomarker identification, allowing for early detection of muscle fatigue, inflammation, and potential injuries. NGS, for instance, enables comprehensive genomic and proteomic analysis from small blood samples, providing detailed insights into an athlete's physiological state. Similarly, mass spectrometry has improved the accuracy of biomarker quantification, leading to more reliable assessments of biochemical changes associated with sports-related stress and injuries.

Key Market Players

• Abbott Laboratories
• BIOMERIEUX
• F. Hoffmann-La Roche Ltd.
• ARUP Laboratories Inc.
• Siemens Healthineers AG
• RayBiotech, Inc
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc
• Beckman Coulter, Inc.
• Randox Laboratories Ltd.

Report Scope

In this report, the Global Blood-based Biomarker For Sports Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood-based Biomarker For Sports Medicine Market, By Type:

• CK
• Myoglobin
• Lactate
• WBC
• Urea
• CRP
• Lipid and Protein Hydroperoxides
• IL-6
• Others

Blood-based Biomarker For Sports Medicine Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood-based Biomarker For Sports Medicine Market.

Available Customizations:

Global Blood-based Biomarker For Sports Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Blood-based Biomarker For Sports Medicine Market

5. Global Blood-based Biomarker For Sports Medicine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6, Others)
  • 5.2.2. By Region
  • 5.2.3. By Company (2024)
• 5.3. Market Map

6. North America Blood-based Biomarker For Sports Medicine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood-based Biomarker For Sports Medicine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
  • 6.3.2. Mexico Blood-based Biomarker For Sports Medicine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
  • 6.3.3. Canada Blood-based Biomarker For Sports Medicine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End Use

7. Europe Blood-based Biomarker For Sports Medicine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Blood-based Biomarker For Sports Medicine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
  • 7.3.2. Germany Blood-based Biomarker For Sports Medicine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
  • 7.3.3. United Kingdom Blood-based Biomarker For Sports Medicine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
  • 7.3.4. Italy Blood-based Biomarker For Sports Medicine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
  • 7.3.5. Spain Blood-based Biomarker For Sports Medicine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type

8. Asia Pacific Blood-based Biomarker For Sports Medicine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value & Volume
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Blood-based Biomarker For Sports Medicine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
  • 8.3.2. India Blood-based Biomarker For Sports Medicine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
  • 8.3.3. South Korea Blood-based Biomarker For Sports Medicine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
  • 8.3.4. Japan Blood-based Biomarker For Sports Medicine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
  • 8.3.5. Australia Blood-based Biomarker For Sports Medicine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type

9. South America Blood-based Biomarker For Sports Medicine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Blood-based Biomarker For Sports Medicine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
  • 9.3.2. Argentina Blood-based Biomarker For Sports Medicine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
  • 9.3.3. Colombia Blood-based Biomarker For Sports Medicine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type

10. Middle East and Africa Blood-based Biomarker For Sports Medicine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value & Volume
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Blood-based Biomarker For Sports Medicine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
  • 10.3.2. Saudi Arabia Blood-based Biomarker For Sports Medicine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
  • 10.3.3. UAE Blood-based Biomarker For Sports Medicine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Blood-based Biomarker For Sports Medicine Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Abbott Laboratories
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. BIOMERIEUX
• 15.3. F. Hoffmann-La Roche Ltd.
• 15.4. ARUP Laboratories Inc.
• 15.5. Siemens Healthineers AG
• 15.6. RayBiotech, Inc
• 15.7. Thermo Fisher Scientific, Inc.
• 15.8. Bio-Rad Laboratories, Inc
• 15.9. Beckman Coulter, Inc.
• 15.10. Randox Laboratories Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer